Discussion about this post

User's avatar
Jenni Majumdar, PhD, CRNA's avatar

"A compelling mechanism in mice is not the same as a proven benefit in people" is a sentence I would like to hand people at six in the morning on the day of surgery. Peptides are the category I now ask about by name, because they almost never appear when someone lists their medications. I have learned to ask twice — once for prescriptions, then once for anything else you take, including anything ordered online or picked up at a health food store — and the second question is where the peptide and the melatonin and the ashwagandha finally show up. The sourcing point is the part that matters most from where I stand. If a compound came from an unregulated supplier, I do not actually know what is in the person in front of me, and that is a different problem from whether the molecule works.

Jeff Bode's avatar

I appreciated the clear line between “interesting biology” and “proven in people.” The part about CB4211 helped. A small 28 day trial in an analog is a very different thing from people online acting like MOTS-c is already settled. That gap gets lost all the time in wellness talk. The note that exercise already raises MOTS-c naturally also felt important. Hard to beat an option that has real human data behind it.

2 more comments...

Ready for more?